Dr. Ashish Rajput, PhD retweeted
Our new paper, “Simply Aging,” is out in @PNASNews!
What is aging, when does it begin, how do we measure it, and what would it take to extend lifespan? We tackle these questions directly and simply.
📄 Read: pnas.org/doi/10.1073/pnas.26…
💬 Discuss: simplyaging.xyz/
I’ve signed the Stand with Jensen letter. Add your name: #standwithjensen #bringjensenback standwithjensen.com/
Dr. Ashish Rajput, PhD retweeted
Founders, you started a company! Congrats, you’re now the chief storyteller.
A lot of technical founders don’t love this part of becoming a CEO. You want to build the product, solve hard problems, and assume that if what you’re building is good enough, people will figure it out.
They probably won’t.
As CEO, perhaps the biggest part of your job is explaining what you’re doing over and over again to investors, customers, candidates, and your own team. You have to make them understand why it matters without assuming they have the same technical context you do.
That doesn’t mean turning into a marketing person or dumbing down what you’re building. It means figuring out how to explain a complicated idea clearly enough that other people actually care. A good test is whether you can explain what you’re building, why it matters, and why now without spending the first ten minutes teaching someone the underlying technology.
Start with the problem and why anyone should care, then go as deep on the technical details as the audience wants to go.
You can build something technically incredible, but at some point you still have to convince people to buy it, fund it, work on it, or believe it should exist. Learning how to tell that story is a huge part of the job too.
I got "Longevity expert" on the Longevity and Biotech Quiz! Try it here: infinity-biosciences.com/lon…
1
47
Dr. Ashish Rajput, PhD retweeted
Day 1 of #ARDD2026 opens at Harvard. George Daley, Dean of Harvard Medical School, kicks off the 13th Aging Research & Drug Discovery Meeting. Full program: agingpharma.org/program2026
I made a Longevity and Biotech Quiz!
Give it a go here: infinity-biosciences.com/lon…
Give it a like and share if you like it. 🙌🖖👨🔬👩🔬
3
178
Great news from VITARNA / ARTAN Bio 🧬
$1M seed round closed, led by @Mykalt45 - fresh off CrossBridge Bio's acquisition by Eli Lilly.
His thesis: back science "with the potential to become category-defining."
$VITARNA
prnewswire.com/news-releases…
On the ground at @DeSciBerlin
Day 2 of DeSci Berlin starts NOW!
Today's lineup covers biotech funding, encrypted longevity data, peptide discovery, and the legal side of self-driving science.
Join us onsite or watch the livestream: xitter.cf/i/broadcasts/1dGYllWkl…
The VitaDAO May Longevity Newsletter is live.
This month:
- Cyclarity reports first Phase 1 data — UDP-003 drove dose-dependent 7KC excretion in humans
- Repair Biotechnologies received FDA RDEP eligibility for REP-0003 in HoFH
- The NAD debate continues, with a new paper and a Kaeberlein–Brenner exchange
- Daewoong acquired a Turn Bio asset
👉Read here: vitadao.com/blog/vitadao-lon…
ATTN innovators ready to change what hearing technology can do.
ARPA-H's Hearing Enhancement through Artificially Intelligent Neurotechnology (HEARING) program is an ambitious new effort to create the first brain driven, minimally invasive hearing system.
We are looking for teams that can bring together breakthroughs in neuroscience, otology, biomedical engineering, microelectronics, AI, machine learning, neuromodulation, clinical audiology, and regulatory science.
Hearing loss affects tens of millions of Americans, shaping how people communicate, work, connect, and move through daily life.
HEARING is designed to push past today’s limits and open a new frontier for people living with hearing loss.
Join us for Proposers’ Day on June 8, 2026.
This hybrid event will take place in Washington, DC, and online.
arpa-h.gov/explore-funding/p…
This is a huge milestone for AI in drug discovery field. Massive capital injection $2.1 Billion for @IsomorphicLabs to take drug discovery efforts forward.
Congratulations @demishassabis and entire @IsomorphicLabs team and all the investors in the round. 🎉👏
I’ve always believed the No.1 application of AI should be to improve human health.
That work started with AlphaFold, and now at @IsomorphicLabs with the mission to reimagine drug discovery and one day solve all disease!
We are turbocharging that goal with $2.1B in new funding.
3
131
Dr. Ashish Rajput, PhD retweeted
peptides and development is going parabolic, we’re bringing together scientists, doctors with years of experience, manufacturers and biohackers
tmrw in Miami - the future of healthcare has arrived
luma.com/xsi6szvh
BIG NEWS!!!
My company Infinity Biosciences is featured in the Top 100 Deep Tech Startups and Top 12 Emerging Pioneers of 2026 by Hello Tomorrow 🎉
See the full post on @LinkedIn
#HelloTomorrow2026 #DeepTechChallenge
#Longevity #Stemcells linkedin.com/posts/dr-ashish…
1
60
Rapamycin is one of the most studied lifespan-extending drugs in animals. So @BradStanfieldMD ran a proper clinical trial to see what happens in humans. @vitadao and @LifespanNews co-funded it 💛
40 people, aged 65-85, all doing the same exercise program for 13 weeks. Half got weekly rapamycin, half got placebo. The placebo group improved more across the board.
Turns out rapamycin stays active for ~62 hours. It was still suppressing muscle recovery when the next workout hit. No clean window to rebuild.
Brad published the negative result honestly. Most negative results never see the light of day. This one is out there for everyone to learn from.
Our Rapamycin & Exercise clinical trial has just been published!
The topline result?
Rapamycin didn't help. Instead, it may have made things worse.
Here's what we found 🧵
onlinelibrary.wiley.com/doi/…
Dr. Ashish Rajput, PhD retweeted
Let’s stay at peak health without limits!
🧬 Vitalist Bay 2026 is T-30 days away
in Berkeley, CA from May 14-17.
Thanks to our partners, join this week & get:
🩸 Free @rythm blood panel
🩻 Free @BodySpec DEXA scan
Full program @ vitalistbay.com
(+ a unique benefit ↓)
Aging is the disease.
We've been funding the research to prove this since 2021.
The goal is to make aging optional. The more people who take this seriously, the faster we get there. 💛
Aging is arguably the root cause of most major diseases. Our cells lose function as we age, allowing various conditions to manifest, which is why most major diseases correlate with age.
Yes, it is more complex than this, but this is a major component. @newlimit is working on treating a root cause of disease (aging) using epigenetic reprogramming.
Dr. Ashish Rajput, PhD retweeted
What the Artemis II astronauts did over the last 10 days was a testament to their bravery. And the fact that they traveled farther from Earth than anyone ever has, re-entered our atmosphere at more than 24,000 mph, and splashed down safely was a testament to human ingenuity. Thanks to everyone at @NASA for making this mission possible, and for taking us along for the ride.

ALT "NASA astronauts Reid Wiseman, commander; left, Christina Koch, mission specialist; CSA astronaut Jeremy Hansen, mission specialist; and NASA astronaut Victor Glover, Artemis II pilot, right, pose for a group photo after viewing the Orion spacecraft in the well deck of USS John P. Murtha on Saturday, April 11, 2026. Photo Credit: NASA/Bill Ingalls"
Our March longevity newsletter is here.
• Rubedo's GPX4 modulator hits positive Phase 1 results in psoriasis and atopic dermatitis
• Cyclarity publishes landmark 7KC review, Phase 1 readout coming later this year
• Eli Lilly signs deal worth up to $2.75B with Insilico Medicine
• ARPA-H commits $144M to aging research
• VitaLabs Season 2 reviews 100+ applications from six continents
Plus portfolio updates and curated longevity science. 👇
vitadao.com/blog/vitadao-lon…






















